Household mold exposure interacts with inflammation-related genetic variants on childhood asthma: a case-control

Yu Zhang1,2, Li Hua3, Quan-Hua Liu3

  • 1Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

Mold exposure and a specific gene variant significantly increase childhood asthma risk. This gene-environment interaction highlights the need to consider genetic factors in asthma prevention strategies.

Area of Science:

  • Environmental Health
  • Genetics
  • Pediatrics

Background:

  • Inconsistent findings exist regarding mold exposure and childhood asthma.
  • Key genes influencing childhood asthma pathogenesis are often overlooked.
  • Limited research explores gene-mold exposure interactions in childhood asthma.

Purpose of the Study:

  • To investigate the interaction between inflammation-related genes and mold exposure on childhood asthma.
  • To identify specific genetic variants that modify the effect of mold exposure on asthma risk.

Main Methods:

  • A case-control study included 645 asthmatic and 910 non-asthmatic children (aged 3-12).
  • Eight single nucleotide polymorphisms (SNPs) in inflammation-related genes were genotyped.
  • Visible mold exposure and SNP associations with childhood asthma were analyzed using logistic regression and crossover analyses for gene-environment interactions.

Main Results:

  • Visible mold exposure was associated with a 2.19-fold increased risk of childhood asthma.
  • The rs7216389 SNP in the GSDMB gene showed a dose-dependent increase in asthma risk.
  • Children with the rs7216389 T allele and mold exposure had a 3.21-fold increased risk of asthma, with significant interaction effects (AP=0.47, RERI=1.49).

Conclusions:

  • A significant additive interaction exists between visible mold exposure and the rs7216389 SNP in childhood asthma.
  • Gene-environment interactions are crucial for understanding childhood asthma risk factors.
  • Future research should incorporate genetic factors alongside environmental exposures.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
931
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K